瘦素在消瘦与肥胖中的作用:JACC最新综述
该综述总结了瘦素生理学及动物、观察性、干预研究和临床试验中瘦素在能量缺乏、肥胖、糖尿病、心血管疾病和非酒精性脂肪肝中的作用,讨论了动物与人类生物学的异同,并介绍了瘦素的临床应用、未来研究方向及新一代瘦素类似物的开发思路。
要点
- 瘦素是脂肪组织分泌的关键激素,传递能量储备信息,调控神经内分泌与能量稳态。
- 瘦素在能量缺乏、肥胖、糖尿病、心血管疾病及非酒精性脂肪肝等代谢疾病中发挥作用。
- 动物与人类研究存在异同,新一代瘦素类似物正在开发中。
核心结论
- 瘦素是脂肪组织分泌的关键激素,调控神经内分泌功能和能量稳态,在多种代谢及心血管疾病中具有重要作用。
研究设计与样本
- 综述总结了瘦素生理学及动物研究、观察性研究、干预研究和人体临床试验的主要发现。
主要发现
- 瘦素在健康状态及能量缺乏、肥胖、糖尿病、心血管疾病、非酒精性脂肪肝等代谢疾病中发挥作用。
- 动物与人类生物学在瘦素作用上存在相似性和差异。
临床怎么用
- 综述讨论了瘦素的临床应用及新一代瘦素类似物的开发方向。
局限性
- 多数机制研究为临床前研究,人体研究较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leptin has emerged over the past 2 decades as a key hormone secreted by adipose tissue that conveys information on energy stores. Leptin is considered an important regulator of both neuroendocrine function and energy homeostasis. Numerous studies (mainly preclinical and much less in humans) have investigated the mechanisms of leptin's actions both in the healthy state as well as in a wide range of metabolic diseases. In this review, the authors present leptin physiology and review the main findings from animal studies, observational and interventional studies, and clinical trials in humans that have investigated the role of leptin in metabolism and cardiometabolic diseases (energy deficiency, obesity, diabetes, cardiovascular diseases, nonalcoholic fatty liver disease). The authors discuss the similarities and discrepancies between animal and human biology and present clinical applications of leptin, directions for future research, and current approaches for the development of the next-generation leptin analogs.
引用
- Perakakis N, Farr OM, Mantzoros CS, et al. Leptin in Leanness and Obesity: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021. PMID: 33573745. doi:10.1016/j.jacc.2020.11.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。